Alder Biopharmaceuticals

ALDR

10.50

+0.25

+2.4%

After Hours:

10.50

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 10.35
Prev. Close: 10.25
Low/Hi: 10.25 - 10.52
52-Week: 8.60 - 26.87
Volumes
Equity: 309,507
90-Day Avg: 1,225,734
Option: 15
90-Day Avg: 230
Volatility
Todays Stock Vol: 27.8
20-Day (HV): 64.5
52-Week (HV): 65.3
30-Day IV: 60.1 +1.1
IV Pct Rank: 4% Subdued
Fundamental
Div. Yield:
Earnings: 22-Feb (Est.)
P/E Ratio:
Market Cap: 694.6 M
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

ALDR Cash Flow

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Sep-2017 30-Jun-2017 31-Mar-2017 31-Dec-2016
Net Income -59,565 -74,629 -100,328 -48,891
Change in Working Capital 8,114 3,063 32,674 -7,675
Depreciation Amortization Depletion and Accretion 752 739 747 660
Deferred Taxes 0 0 0 0
Other Non-Cash Activities 5,862 5,972 5,508 4,374
Total Cash from Operating Activities -44,837 -64,855 -61,399 -51,532
Capital Expenditures -470 -677 -849 -1,057
Other Investing Cash Flow -146,720 112,965 25,674 -2,775
Total Cash from Investing Activities -147,190 112,288 24,825 -3,832
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 161,572 643 71 948
Purchase and Retirement of Debt 0 0 0 0
Other Financing Cash Flow 0 0 0 0
Total Cash from Financing Activities 161,572 643 71 948
Exchange Rate Effects 0 0 0 0
Net Change in Cash -30,455 48,076 -36,503 -54,416
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014
Net Income -156,254 -85,470 8,908
Change in Working Capital -18,606 -2,670 -58,518
Depreciation Amortization Depletion and Accretion 1,674 751 701
Deferred Taxes 0 0 0
Other Non-Cash Activities 13,499 6,156 1,252
Total Cash from Operating Activities -159,687 -81,233 -47,657
Capital Expenditures -6,619 -1,223 -649
Other Investing Cash Flow -61,101 -166,044 -9,085
Total Cash from Investing Activities -67,720 -167,267 -9,734
Dividends and Distributions 0 0 0
Purchase or Sale of Stock 137,110 408,170 81,018
Purchase and Retirement of Debt 0 0 0
Other Financing Cash Flow 0 36 -36
Total Cash from Financing Activities 137,110 408,206 80,982
Exchange Rate Effects 21 -9 -23
Net Change in Cash -90,276 159,697 23,568